FDA Approves new gene altering cancer treatment

This is an incredible development that was just approved on Wednesday october 18th 2017. FDA Approves new gene altering cancer treatment. In short the treatment involves taking millions of the patients T-cells, freezing them and shipping them to a processing facility, in El Segundo, California where they will be genetically altered to kill cancer cells, refrozen, shipped back to the patient and then dripped back into the patient.

This treatment is VERY expensive and must be manufactured individually for EACH patient at a cost of around $475,000. According to the NY Times article the company will not charge patients who do not respond within the first month.



Who can be approved

This treatment is “approved for adults with aggressive forms of a blood cancer, non-Hodgkin’s lymphoma, who have undergone two regimens of chemotherapy that failed.”  said the NY times article.

The treatment has some pretty serious side effects also.  Here is the full article for more information:

https://www.nytimes.com/2017/10/18/health/immunotherapy-cancer-kite.html